ProCE Banner Activity

Relapsed/Refractory Multiple Myeloma: Subsequent Therapy and Beyond

Slideset Download
Download these expert-selected slides on current best practices for later-stage relapsed/refractory multiple myeloma and investigational agents in this setting.

Released: September 22, 2022

Expiration: September 21, 2023

Share

Faculty

Paul G. Richardson

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Medical Learning Institute, Inc. in partnership with Clinical Care Options, LLC.
ProCE Banner

Supporters

Supported by educational grants from

Janssen administered by Scientific Affairs

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Paul G. Richardson, MD

Associate Professor of Medicine
Harvard Medical School
Clinical Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Boston, Massachusetts